pillbase.ru

Selexipag

Active substance: selexipag

TABLET, FILM COATED · SELEXIPAG 600 ug/1

United StatesActive

Marketing holder: Zydus Lifesciences Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Uptravi
    selexipag
    EMEA/H/C/003774
    Janssen Cilag International NV
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-45ff-7ce2-9cfe-d2b9c82b1a70,01a1208c-bb5c-76d0-9383-a070e346f46e,01a1208c-bcca-71e0-b66b-49e1d020e12d,01a1208c-bccc-7d61-8a65-dd8c3dab8d73,01a1208c-f5d6-7e87-9bfa-089937645f8f;count=40 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70771-1795
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 70771-1795 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70771-1795 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70771-1795 · Verified 2026-10-09 · open in source